BRITTANY KIRCHNER: Open Payments
NPI 1831636406 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 33 payments from 14 companies in 2025. Trend: 2023 $534 · 2024 $595 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Philips North America LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Exact Sciences Corporation | 2 | $29 |
Products named: JARDIANCE, REXULTI, UBRELVY, Ambulatory Monitoring & Diagnostics Undivided, AIRSUPRA, Ozempic, MOUNJARO, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
